Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 8 Feb 21 424B4 Prospectus supplement with pricing info
- 5 Feb 21 EFFECT Notice of effectiveness
- 3 Feb 21 F-1/A Registration statement (foreign) (amended)
-
1 Feb 21 F-1/A Registration statement (foreign) (amended)
- 15 Jan 21 F-1 Registration statement (foreign)
IMCR similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Immunocore Holdings Limited:
We consent to the use of our report dated January 15, 2021, with respect to the statement of financial position of Immunocore Holdings Limited as of January 7, 2021, and the related note, included herein and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP
London, United Kingdom
February 1, 2021